Pharvaris (PHVS) holder Berndt Modig files to sell 2,292 shares
Rhea-AI Filing Summary
PHVS shareholder Berndt B.A.E. Modig has filed to sell up to 2,292 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an indicated aggregate value of $80,380.44 for a planned trade date of July 13, 2026. The shares relate to Restricted Stock Units dated July 11, 2026 and the filing also lists prior Rule 10b5-1 sales in April, May, and June 2026 of about 2,291–2,292 shares each, with aggregate values between $65,558.53 and $71,172.89.
Positive
- None.
Negative
- None.
Filing Explained
The July 13 filing reports a proposed 2,292-share disposition, not a completed sale, with no disclosed issuer-level proceeds or dilution.
This Form 144 lists
The filing gives July 11, 2026 as the relevant date for the listed securities and identifies the issuer as the source of the restricted stock units.
It also lists three earlier sales—
A Rule 10b5-1 plan is a written trading plan adopted in advance that executes trades on a schedule or formula, and the filing disclosing one states its adoption date rather than the reasons for individual trades.
Unlike those three historical entries, the current proposed-sale entry does not disclose a 10b5-1 plan.
Key Figures
Key Terms
Form 144 regulatory
Rule 10b5-1 regulatory
Restricted Stock Units financial
Executive Financial Services financial
AI-generated analysis. How Rhea-AI works. Not financial advice.